An interventional study of Snoo smart bassinet and Willow wearable breast pump in Pregnancy Related, Burnout, Professional and Wellness, Psychological, sponsored by Massachusetts General Hospital. Completed at 7 sites in United States. Open to female participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-14.
Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 97 studies in Burnout, Professional with a site in United States — 11 open to participants now, 16 under way, none of them phase 3. Burnout, Professional · United States.
Among the 97 studies in Burnout, Professional with a site in United States, this one is the 25th largest by enrollment of the 90 interventional ones that give a count, is one of 18 that started in 2023, is one of 88 with no phase, and was the 82nd registered.
218 studies on the registry are indexed under Burnout, Professional; 35 are open to participants now.
Browse Burnout, Professional studies →11 of the 97 studies in Burnout, Professional with a site in United States are open now. Recruiting first, the newest first:
Efforia, Inc · Sites in United States
Ages 18+ · Healthy volunteers
Lancaster General Hospital · Sites in United States
Ages 25–70 · Healthy volunteers
University of Arkansas · Sites in United States
Ages 18+ · Healthy volunteers
Michelle Thompson · Sites in United States
Ages 18+ · Healthy volunteers
University of Michigan · Sites in United States
Ages 18+ · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 14 Burnout, Professional studies recruiting now, 9 (64%) set no upper age limit and 5 (36%) stop at 75 or younger; 1 takes children under 18; 9 take healthy volunteers.
This study: female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
97 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 18 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 156 is above the median of 80 across 162 interventional studies indexed under Burnout, Professional.
Median enrollment 77 across the 90 interventional studies, 246 across the 7 observational. Of the 76 that completed or were terminated, 8 (11%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 97 have an industry lead sponsor. The 10 most frequent:
Massachusetts General Hospital is the lead sponsor of 2,591 studies on the registry; 445 are open to participants now.
Of its 224 completed or terminated interventional studies of FDA-regulated products, 168 (75%) have results posted.
Massachusetts General Hospital has 7 studies filed under Burnout, Professional — fewer than ten, so there is no comparison to draw.
8 of the studies in Burnout, Professional with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07221422Massachusetts General HospitalThe PREGNANT (Pregnant Resident Empowerment, GuidaNce, and Advocacy iN Training) Coaching Project | 2026-11-30 |
| NCT05942469Northwestern UniversityFostering Optimal Regulation of Emotion for Prevention of Secondary Trauma (FOREST) | 2026-12-31 |
| NCT03063372University of Mississippi Medical CenterPomegranate Supplementation and Well-Being Among Medical Students and Residents | 2027-02-01 |
| NCT05713669University of MichiganImpact of Resident Participation in Post-ICU Follow Up Clinic | 2027-04 |
| NCT07262372University of ArkansasSupervision in Substance Use Disorder Treatment Programs | 2027-05-31 |
Add all 8 to your calendar (.ics) → With an account.
Among the 97 studies in Burnout, Professional with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to determine the impact of a parental support package for new trainee mothers which focuses on mentorship, lactation, and sleep, and access to perinatal care. The main questions it aims to answer are whether this set of interventions will improve trainee wellbeing and decrease medical error.
Participants will be randomized to intervention and control groups. The intervention group will receive:
The control group will receive the standard support currently offered by training programs.
All participants will wear a Fitbit to track sleep and will take a series of surveys querying pregnancy, birth, and postpartum experiences; wellbeing; and professional satisfaction.
Researchers will compare intervention and control groups to see if the intervention group has:
The birth of a child during training is a significant life event that has been associated with a high risk of attrition and career dissatisfaction. Post-graduate training lasts between 3 and 9 years after medical school and overlaps with peak child-bearing years. The difficulties facing new trainee parents have been characterized with stigma, health concerns due to unmitigated work schedules during pregnancy, short parental leaves, and challenges with lactation and childcare contributing to stress and fatigue. Program directors describe marked variability in how childbearing affected residents' quality of work, with many describing returning residents as conflicted and distracted. The increase in family commitments in the setting of existing training demands can lead trainees to develop a perception of work-life incompatibility, fatigue, to change their career trajectory, and to have increased risk of burnout and postpartum depression. The investigators hypothesize that a set of interventions for new trainee mothers, focusing on mentorship, lactation, and sleep can improve trainee wellbeing and decrease the risk of medical errors.
STUDY PROCEDURES:
This study is designed as a prospective randomized clinical trial of pregnant trainees at Massachusetts General Hospital (MGH), Brigham and Women's Hospital (BWH), Boston Children's Hospital (BCH), and Beth Israel Deaconess Medical Center (BIDMC), Brown Medical Center, Hartford Health, and Tufts Medical Center.
Participants will be screened over the phone and consent to participate obtained in person. All participants will take the electronic pre-intervention assessment survey after consent. After completion of the pre-intervention assessment survey, participants will be randomized into either the control arm or the intervention arm and provided a wearable device to monitor sleep (for one week during pregnancy to establish a baseline and for 6 months after delivery).
After delivery, all participants will take a set of surveys at 4,12,16,20,24, and 52 weeks postpartum querying obstetric and postpartum experiences; self-reported medical error; fatigue; wellbeing; and professional satisfaction.
The intervention group will receive:
The control group will receive standard parental support currently offered by training programs.
Researchers will compare the following between intervention and control groups:
The investigators plan to measure mean scores in burnout as our primary outcome. An effect size of 0.5 standard deviation change in burnout between the control and intervention arm is estimated to be a clinically relevant change. Trainees have mean burnout scores of 3.35 (SD=2.05). 78 subjects in each arm are estimated to be needed, 156 participants total, to detect a statistically significant change in burnout score (by at least 1.025 using the SPFI), with 80% power with a two tailed alpha of 5%, and allowing for 20% attrition of study subjects.
STATISTICAL ANALYSIS The investigators plan to report descriptive data including frequency, mean (SD) and median (inter-quartile range) for all outcome measures, using chi-squared analyses for categorical variables and t-test for continuous variables.
Mass General Brigham (MGB) has more than 200 training programs across its training sites. Of the 27/200+ programs that responded to a brief survey through the Wellbeing Council, 76 trainees (43 men and 33 women) became new parents this past academic year (2020-2021). Human Resources at MGB estimates more than 70 trainees apply for formal parental leave yearly which likely significantly underestimates the true number of new parents as most nonchildbearing parent trainees do not take formal parental leave. Based on this information, the investigators anticipate that the MGB training programs alone will have a sufficient number of trainees to conduct this study.
STUDY TERMINATION CRITERIA:
The study will be terminated at the request of the participant for any reason. Otherwise, the study will be terminated at 6 months. Subjects in the control arm who purchase a SNOO bassinet or a wearable breast pump will be requested to notify the study PI and will be categorized as a subgroup and analyzed in a planned sub-group analysis.
MONITORING AND QUALITY ASSURANCE:
To minimize the risk of loss of anonymity, participants will be assigned a unique study identifier. Access to files linking identifiers with identifying coded data will be limited only to need-to-know study personnel and stored in a Partners Password Protected online storage drive, while survey data will be obtained using Partners REDCap. Data will be accessible only to the PI and CITI-certified research staff. The Research staff will review the database each time new patient data is collected using a Partners password-protected computer and the PI will review the database once a month with details discussed at a monthly research meeting.
Identifying information (name, email address, phone number, shipping address, and due date) will need to be released to the sponsoring companies to facilitate delivery of the automated bassinet (Happiest Baby Inc), wearable breast pump (Willow Innovations) and access to perinatal on-demand consultation (Maven Clinic). Data transfer will be performed via MGB approved password protected and encrypted mechanisms. Both companies have designated representatives that are HIPAA certified with no association to the study execution or analysis. Data access by the company representatives will require multi-factor identification for the single user who will be allowed access. The transferred information will be used to order study related equipment for participants. The data will be deleted from the secure electronic location at the conclusion of the study.
Sleep tracking data is housed in secure Azure (Microsoft) servers. Fitabase uses Secure Sockets Layer (SSL) for all authentication (logins), billing, and administration of the site. The user's browser establishes the authenticity by requesting an SSL certificate that verifies the identity of Fitabase. Once that SSL certificate is recognized, a Secure Sockets Layer (SSL) connection is established for security, encrypting data transmitted between browser and web server.
Participants will be asked in person or online to authorize use of Fitabase to access their wearable device data and make it available for download for analysis. Participants will be informed that research staff will be able to access, view, and download deidentified data through the Fitabase platform. Data collected will relate to sleep length, movement, and quality. There are two instances when the PI will revoke access to data associated with participants in this study. First, if a participant chooses to withdraw from the study, the PI will remove the participant from the study platform (Fitabase) and data will be removed from the study. Second, 90 days after the completion of data collection Fitabase will remove the project from their data management system, disassociate the data from the project, and begin remove access to the data by deleting it from its servers and backup systems.
The PI will be responsible for determining whether the research should be altered or stopped. Throughout the duration of the study, the PI will perform ongoing evaluation of subject safety data to identify adverse events and trends as soon as possible. Any unanticipated adverse events involving risk to human subjects will be reviewed by the Principal Investigator and will be quickly reported to the Human Research Committee within the required time frame and to all participating investigators by The PI according to the Partners Human Research Committee guidelines.
The criteria were revised on the registry on Oct 14, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The intervention group will receive: 1. A Snoo smart sleep bassinet 2. A Willow wearable breast pump 3. Access to Maven Clinic for 24/7 on-demand perinatal care 4. A faculty mentor in their own department
Device: Snoo smart bassinet · Device: Willow wearable breast pump · Behavioral: Maven Clinic on-demand perinatal consultation · Behavioral: Faculty mentor
The control arm will receive: Current standard in the residency training program.
Participants in the intervention arm will be shipped a Snoo bassinet during their third trimester. The bassinet must be returned to the company at 6 months
Participants in the intervention arm will be shipped a Willow wearable breast pump and milk storage bags during the third trimester, which participants may keep
Participants in the intervention arm will receive immediate access to Maven Clinic for 24/7 on-demand consultation with perinatal specialists.
After enrollment, participants in the intervention arm will be paired with a faculty mentor who is also a mother to discuss issues related to work-family integration during pregnancy and early infancy.
Burnout Score
Burnout comprises 2 of the 3 subscales within the Stanford Professional Fulfillment Index; scores range from 0 to 10. Higher scores indicate greater burnout.
Time frame: At Enrollment; 24 weeks postpartum
Component of Primary Outcome: Emotional Exhaustion Score
Emotional exhaustion is a subscale of the Stanford Professional Fulfillment Index; score range is 0 to 10. Higher scores indicate more emotional exhaustion.
Time frame: At Enrollment; 24 weeks postpartum
Component of Primary Outcome: Interpersonal Disengagement Score
Interpersonal disengagement is a subscale of the Stanford Professional Fulfillment Index; score is 0 to 10. Higher scores indicate more interpersonal disengagement.
Time frame: At Enrollment; 24 weeks postpartum
Professional Fulfillment Score
Professional fulfillment is a subscale of the Stanford Professional Fulfillment Index; score range is 0 to 10. A score of greater than or equal to 7.5 indicates high professional fulfillment.
Time frame: At Enrollment; 24 weeks postpartum
Number of Participants With High Professional Fulfillment
Professional fulfillment is a subscale of the Stanford Professional Fulfillment Index; score range is 0 to 10. A score of greater than or equal to 7.5 indicates high professional fulfillment. The values reported represent the number of participants meeting this criterion.
Time frame: At Enrollment; 24 weeks postpartum
Organizational and Personal Values Alignment Score
Organizational and personal values alignment score range is 0 to 12; higher scores indicate greater alignment.
Time frame: At Enrollment; 24 weeks postpartum
Work Impact on Personal Relationships Score
Work impact on personal relationships score range is 0 to 10; higher scores indicate greater adverse impact.
Time frame: At Enrollment; 24 weeks postpartum
Number of Participants With Career Regret
Career regret was defined as an affirmative response to at least 1 of the following statements: "I have considered leaving my program in the last year"; "If I could choose again, I would choose a non-medical career"; or "I would stay in medicine but choose a specialty that is more accommodating." The outcome represents the number of participants meeting this criterion at each time point.
Time frame: At Enrollment; 24 weeks postpartum
Sleep-related Impairment Score
Patient Reported Outcomes Measurement Information System (PROMIS) sleep-related impairment score range is 8 to 40. A score greater than or equal to 22 indicates very high impairment. Scores were calculated according to published instrument scoring algorithms; no post survey normalization or rescaling was performed.
Time frame: At enrollment; and 24 weeks postpartum
Trainees were recruited through a GME administered email flyer. Ongoing identification of potential trainees suitable for study was made by the program director of the training program or self. Subjects could either self-identify or could be identified by training program directors by expressing interest via email to the study PI or study personnel. The study PI or study personnel reviewed requests and recruited individuals into the study. More details in study protocol.
| Milestone | Intervention | Control |
|---|---|---|
| Started | 78 | 78 |
| Took 16 weeks or more of leave | 7 | 3 |
| Completed | 78 | 75 |
| Not completed | 0 | 3 |
| Withdrew: Withdrawal by subject | 0 | 2 |
| Withdrew: Lost to follow-up | 0 | 1 |
Burnout comprises 2 of the 3 subscales within the Stanford Professional Fulfillment Index; scores range from 0 to 10. Higher scores indicate greater burnout.
| Points | Intervention | Control |
|---|---|---|
| Baseline | 2.8 (1.5 to 4.2) | 3.1 (2.0 to 4.0) |
| 24 Weeks Postpartum | 2.6 (1.6 to 4.2) | 3.7 (2.8 to 4.8) |
Professional fulfillment is a subscale of the Stanford Professional Fulfillment Index; score range is 0 to 10. A score of greater than or equal to 7.5 indicates high professional fulfillment.
| Score | Intervention | Control |
|---|---|---|
| Baseline | 7.1 (5.8 to 7.7) | 7.1 (5.8 to 7.6) |
| 24 Weeks Postpartum | 7.1 (5.4 to 7.5) | 6.2 (5.0 to 7.5) |
Professional fulfillment is a subscale of the Stanford Professional Fulfillment Index; score range is 0 to 10. A score of greater than or equal to 7.5 indicates high professional fulfillment. The values reported represent the number of participants meeting this criterion.
| Participants | Intervention | Control |
|---|---|---|
| Baseline | 34 | 31 |
| 24 Weeks | 28 | 19 |
Organizational and personal values alignment score range is 0 to 12; higher scores indicate greater alignment.
| Score | Intervention | Control |
|---|---|---|
| Baseline | 7.0 (5.0 to 9.0) | 7.0 (5.0 to 8.2) |
| 24 Weeks Postpartum | 8.0 (5.0 to 9.0) | 6.0 (4.0 to 8.0) |
Emotional exhaustion is a subscale of the Stanford Professional Fulfillment Index; score range is 0 to 10. Higher scores indicate more emotional exhaustion.
| Score | Intervention | Control |
|---|---|---|
| Baseline | 3.8 (2.5 to 5.0) | 3.8 (3.0 to 5.0) |
| 24 Weeks Postpartum | 3.1 (2.5 to 5.0) | 4.4 (3.1 to 5.6) |
Work impact on personal relationships score range is 0 to 10; higher scores indicate greater adverse impact.
| Points | Intervention | Control |
|---|---|---|
| Baseline | 2.5 (1.2 to 4.4) | 3.1 (1.7 to 5.0) |
| 24 Weeks Postpartum | 3.8 (1.9 to 5.6) | 5.0 (3.1 to 6.9) |
Career regret was defined as an affirmative response to at least 1 of the following statements: "I have considered leaving my program in the last year"; "If I could choose again, I would choose a non-medical career"; or "I would stay in medicine but choose a specialty that is more accommodating." The outcome represents the number of participants meeting this criterion at each time point.
| Participants | Intervention | Control |
|---|---|---|
| Baseline | 20 | 21 |
| 24 Weeks Postpartum | 30 | 40 |
Interpersonal disengagement is a subscale of the Stanford Professional Fulfillment Index; score is 0 to 10. Higher scores indicate more interpersonal disengagement.
| Score | Intervention | Control |
|---|---|---|
| Baseline | 2.1 (0.2 to 3.3) | 2.5 (0.4 to 3.3) |
| 24 Weeks Postpartum | 2.5 (0.0 to 3.3) | 2.7 (1.7 to 4.2) |
Patient Reported Outcomes Measurement Information System (PROMIS) sleep-related impairment score range is 8 to 40. A score greater than or equal to 22 indicates very high impairment. Scores were calculated according to published instrument scoring algorithms; no post survey normalization or rescaling was performed.
| Score | Intervention | Control |
|---|---|---|
| Baseline | 20 (16.5 to 25) | 21 (17 to 26) |
| 24 Weeks Postpartum | 19.0 (13.5 to 25) | 24 (17 to 27) |
Change from enrollment to 24 weeks postpartum in the percentage of participants with a burnout score greater than or equal to 3.325. High burnout was defined as a burnout score greater than or equal to 3.325. The percentage of participants with high burnout at enrollment was subtracted from the percentage of participants with high burnout at 24 weeks postpartum (24-week percentage minus enrollment percentage). Negative values indicate a decrease in the percentage of participants with high burnout from enrollment to 24 weeks postpartum; positive values indicate an increase. This was analyzed as a post hoc exploratory outcome.
| % points in participants w/ high burnout | Intervention | Control |
|---|---|---|
| Change in Percentage of Participants With High Burnout | -7.1 (-21.1 to 7.0) | 20.9 (8.4 to 33.3) |
Collected over Deaths and adverse events were not collected from enrollment to 24 weeks postpartum. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Intervention | — | — | — |
| Control | — | — | — |
Among 156 participants, 78 were randomized into the parental support package group and 78 into the usual support group. Three did not complete the study and 10 were excluded for taking 16 weeks of leave or longer. The analysis included 143 participants (72 in the usual support group and 71 in the parental support package group; median age, 32 \[IQR, 31-34\] years).
| Age, Continuous(years) | Intervention | Control | Total |
|---|---|---|---|
| Median | 32 (31 to 34) | 32 (30 to 33) | 32 (31 to 34) |
| Sex/Gender, Customized(Participants) | Intervention | Control | Total |
|---|---|---|---|
| Female | 71 | 72 | 143 |
| Race/Ethnicity, Customized(Participants) | Intervention | Control | Total |
|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 |
| Asian | 17 | 19 | 36 |
| Black or African American | 3 | 5 | 8 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 |
| White | 42 | 41 | 83 |
| Other | 2 | 3 | 5 |
| More than 1 race | 7 | 4 | 11 |
| Hispanic or Latino | 2 | 6 | 8 |
| Not Hispanic or Latino | 69 | 66 | 135 |
| Number of additional children(Participants) | Intervention | Control | Total |
|---|---|---|---|
| 0 | 52 | 60 | 112 |
| Greater than or equal to 1 | 19 | 12 | 31 |
| Pregnancy trimester at enrollment(Participants) | Intervention | Control | Total |
|---|---|---|---|
| First trimester (0 wk 0 d to 13 wk 6 d) | 19 | 16 | 35 |
| Second trimester (14 wk 0 d to 27 wk 6 d) | 30 | 42 | 72 |
| Third trimester (28 wk 0 d to delivery) | 22 | 14 | 36 |
| Relationship status(Participants) | Intervention | Control | Total |
|---|---|---|---|
| Married | 67 | 70 | 137 |
| Committed and/or long-term relationship | 2 | 2 | 4 |
| Single | 1 | 0 | 1 |
| Divorced or separated and single | 1 | 0 | 1 |
| Domestic partner work hours(Participants) | Intervention | Control | Total |
|---|---|---|---|
| Stay at home or less than 40 hours/week | 4 | 2 | 6 |
| 40-59 hours/week | 44 | 43 | 87 |
| Greater than or equal to 60 hours/week | 21 | 27 | 48 |
| No partner | 2 | 0 | 2 |
| Domestic partner occupation(Participants) | Intervention | Control | Total |
|---|---|---|---|
| Attending physician or surgeon | 5 | 5 | 10 |
| Other paid occupation | 43 | 48 | 91 |
| Resident/fellow | 16 | 19 | 35 |
| Student/stay-at-home-parent | 5 | 0 | 5 |
| No partner | 2 | 0 | 2 |
7 further baseline measures are reported on the registry.
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No — Individual participant data will not be shared as this it contains sensitive information that is best presented in aggregate to ensure anonymity of participants
Ran from May 2023 to primary completion in May 2025, 24 months.
Results were first posted in Oct 2026, 1 year 4 months after primary completion.
Of 128 non-industry interventional studies with no phase under Burnout, Professional, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 22. This study's 24 months is above that.
Counting every sponsor, half of 132 studies reached it within 11 months; a quarter within 6 and three quarters within 23.
Primary completion moved once since we started tracking on Sep 25, 2026: Jan 2026 → May 2025, on Oct 14, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Massachusetts General Hospital →